May 18, 2020 / 11:41 AM / 16 days ago

BRIEF-Turning Point Therapeutics Expects To Report Preliminary Data From Multiple Phase 2 Cohorts Of Trident-1 In H2 2020

May 18 (Reuters) - Turning Point Therapeutics Inc:

* TURNING POINT THERAPEUTICS - ANTICIPATE REPORTING PRELIMINARY DATA FROM MULTIPLE PHASE 2 COHORTS OF TRIDENT-1 IN THE SECOND HALF OF 2020

* TURNING POINT THERAPEUTICS - PENDING SUCCESSFUL COMPLETION OF IND-ENABLING STUDIES, ANTICIPATE SUBMITTING AN IND FOR TPX-0131 IN EARLY 2021 Source text: [bit.ly/2WFzoJ4] Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below